Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension

被引:249
作者
Jing, Zhi-Cheng
Xu, Xi-Qi
Han, Zhi-Yan
Wu, Yan
Deng, Ke-Wu
Wang, Hao
Wang, Zeng-Wu
Cheng, Xian-Sheng
Xu, Bo
Hu, Sheng-Shou
Hui, Ru-Tai
Yang, Yue-Jin
机构
[1] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Fu Wai Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Dept Internal Med, Beijing 100037, Peoples R China
[4] Chinese Acad Med Sci, Dept Pathol, Beijing 100037, Peoples R China
[5] Chinese Acad Med Sci, Dept Anesthesiol, Beijing 100037, Peoples R China
[6] Chinese Acad Med Sci, Dept Echocardiography, Beijing 100037, Peoples R China
[7] Chinese Acad Med Sci, Dept Epidemiol, Beijing 100037, Peoples R China
[8] Chinese Acad Med Sci, Dept Cardiovasc Surg, Beijing 100037, Peoples R China
[9] Chinese Acad Med Sci, Sino German lab mol Med, Beijing 100037, Peoples R China
关键词
pulmonary arterial hypertension; registry; survival rate;
D O I
10.1378/chest.06-2913
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Background: To evaluate the clinical features and survival data of patients with idiopathic pulmonary arterial hypertension (PAH) and familial PAH in Chinese patients. Methods: Seventy-two patients with idiopathic PAH and familial PAH were enrolled in the study from 1999 to 2004 and were classified into two groups according to World Health Organization (WHO) functional class (I/II and III/IV). Clinical and hemodynamic data were recorded. Results: The mean age of the 72 patients was 35.9 years with female patient/male patient ratio of 2.4:1. A significant difference was identified in the clinical presentation between two WHO functional class groups at baseline. Echocardiography showed a mean pulmonary systolic pressure of 98 mm Hg. Left ventricular end-diastolic diameter was significantly smaller in the group of patients in WHO functional class III/IV than in those in class I/II group. After follow-up for a mean (+/- SD) duration of 40.1 +/- 20.0 months, the survival rates at 1, 2, 3, and 5 years were 68.0%, 56.9%, 38.9%, and 20.8%, respectively. A significant difference was identified in survival rate between the class I/II and class III/IV groups (p = 0.02 [log rank test]). Conclusions: The baseline characteristics and survival rates of our cohort study are close to those of the National Institutes of Health Registry in the 1980s, and the I-year survival rate is obviously lower for patients in this registry than for those in the French registry between 2002 to 2003. Lack of effective treatment was the main cause of poor survival in this study. Our results support
引用
收藏
页码:373 / 379
页数:7
相关论文
共 17 条
[1]
Bossone E, 2003, CAN J CARDIOL, V19, P544
[2]
CARCAMO J, 1995, MOL CELL BIOL, V15, P1573
[3]
SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].
DALONZO, GE ;
BARST, RJ ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
KERNIS, JT ;
LEVY, PS ;
PIETRA, GG ;
REID, LM ;
REEVES, JT ;
RICH, S ;
VREIM, CE ;
WILLIAMS, GW ;
WU, M .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349
[4]
PRIMARY PULMONARY HYPERTENSION .1. CLINICAL AND HEMODYNAMIC STUDY [J].
DRESDALE, DT ;
SCHULTZ, M ;
MICHTOM, RJ .
AMERICAN JOURNAL OF MEDICINE, 1951, 11 (06) :686-705
[6]
Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology [J].
Galiè, N ;
Torbicki, A ;
Barst, R ;
Dartevelle, P ;
Haworth, S ;
Higenbottam, T ;
Olschewski, H ;
Peacock, A ;
Pietra, G ;
Rubin, LJ ;
Simonneau, G .
EUROPEAN HEART JOURNAL, 2004, 25 (24) :2243-2278
[7]
End points and clinical trial designs in pulmonary arterial hypertension - Clinical and regulatory perspectives [J].
Hoeper, MM ;
Oudiz, RJ ;
Peacock, A ;
Tapson, VF ;
Haworth, SG ;
Frost, AE ;
Torbicki, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :48S-55S
[8]
Pulmonary arterial hypertension in France - Results from a national registry [J].
Humbert, M ;
Sitbon, O ;
Chaouat, A ;
Bertocchi, M ;
Habib, G ;
Gressin, V ;
Yaici, A ;
Weitzenblum, E ;
Cordier, JFO ;
Chabot, F ;
Dromer, C ;
Pison, C ;
Reynaud-Gaubert, M ;
Haloun, A ;
Laurent, M ;
Hachulla, E ;
Simonneau, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (09) :1023-1030
[9]
Bone morphogenetic protein receptor-II mutation Arg491Trp causes malignant phenotype of familial primary pulmonary hypertension [J].
Jing, ZC ;
Lu, LH ;
Han, ZY ;
Cheng, XS ;
Zou, YB ;
Yang, YJ ;
Hui, RT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (04) :1033-1038
[10]
Now predictors of outcome in idiopathic pulmonary arterial hypertension [J].
Kawut, SM ;
Horn, EM ;
Berekashvili, KK ;
Garofano, RP ;
Goldsmith, RL ;
Widlitz, AC ;
Rosenzweig, EB ;
Kerstein, D ;
Barst, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (02) :199-203